Details for Patent: 12,629,338
✉ Email this page to a colleague
Which drugs does patent 12,629,338 protect, and when does it expire?
Patent 12,629,338 protects DESCOVY and is included in one NDA.
This patent has fifty-nine patent family members in twenty-six countries.
Drugs Protected by US Patent 12,629,338
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | DESCOVY | emtricitabine; tenofovir alafenamide fumarate | TABLET;ORAL | 208215-001 | Apr 4, 2016 | AB | RX | Yes | Yes | 12,629,338 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,629,338
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2016287500 | ⤷ Start Trial | |||
| Australia | 2019210558 | ⤷ Start Trial | |||
| Australia | 2021202009 | ⤷ Start Trial | |||
| Brazil | 112017027843 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
